DCI 16 (Pertzye amylase 60,500 units; lipase 16,000 USP units; protease 57,500 USP units)

Generic Name: pancrelipase

Pill imprint DCI 16 has been identified as Pertzye amylase 60,500 units; lipase 16,000 USP units; protease 57,500 USP units.

Pertzye is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Pertzye amylase 60,500 units; lipase 16,000 USP units; protease 57,500 USP units is not a controlled substance under the Controlled Substance Act (CSA).

Pertzye

Generic Name:

pancrelipase

Imprint:

DCI 16

Strength:

amylase 60,500 units; lipase 16,000 USP units; protease 57,500 USP units

Color:

Clear / Red

Shape:

Capsule-shape

Availability:

Rx and/or OTC

Drug Class:

Digestive enzymes

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Digestive Care, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.